By Dawn Chmielewski (Reuters) -A special committee of the Paramount Global board charged with evaluating offers for the company met Saturday morning, though rival bidders
Month: May 2024
Saudi Arabia’s non-oil business activity growth steady in April-PMI
DUBAI (Reuters) – Saudi Arabia’s non-oil business activity grew at a steady rate in April despite a slowdown in new order growth, a survey showed
Berkshire pares huge Apple stake as cash, operating profit set records
By Jonathan Stempel OMAHA, Neb. (Reuters) – Berkshire Hathaway significantly reduced its enormous stake in Apple in the first quarter, as Warren Buffett’s conglomerate let
Fed’s Williams says 2% inflation target ‘critical’
By Ann Saphir PALO ALTO, California (Reuters) -The U.S. central bank’s 2% target for inflation is key to achieving price stability and essential for ensuring
NATO drills show it is preparing for potential conflict with Russia, Moscow says
MOSCOW (Reuters) – NATO’s four-month long military exercises near Russia’s borders, known as Steadfast Defender, are proof the alliance is preparing for a potential conflict
Google trial wraps up as judge weighs landmark US antitrust claims
By Mike Scarcella WASHINGTON (Reuters) -Google and the U.S. Justice Department wrapped up closing arguments on Friday over claims that the Alphabet unit has unlawfully
Exxon to take 18-24 months to hit full stride with Pioneer purchase
By Sabrina Valle HOUSTON (Reuters) -Exxon Mobil will take 18 to 24 months to achieve its full production synergies from its $60 billion purchase of
Tech platforms make pitch for ad deals as TikTok is roiled by politics
By Sheila Dang (Reuters) – Short-form video took center stage at tech and social media companies’ annual presentations to advertisers, as platforms like Snap and
Apple shares jump as record buyback and upbeat forecast lure investors
By Aditya Soni (Reuters) -Apple shares jumped 7% on Friday as the iPhone maker’s record stock buyback plan and promise of sales growth brought back
Amgen jumps after teasing weight-loss drug data, rival stocks fall
By Manas Mishra and Christy Santhosh (Reuters) -Amgen shares headed for their best session since 2009 on Friday after the U.S. drugmaker hinted at encouraging